Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma
- Creator: Mercieca-Bebber, R. , Barnes, E. H. , Leung, J. , Wang, T. , Bohmer, R. , Cameron, D. , Simes, J. , Gebski, V. , Smithers, M. , Thomas, J. , Zalcberg, J. , Barbour, A. P. , Wilson, K. , Samoon, Z. , Walpole, E. , Mai, T. , Ackland, S. , Burge, M. , Dickie, G. , Watson, D.
- Resource Type: journal article
- Date: 2022
Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial
- Creator: Barbour, A. P. , Walpole, E. T. , Mai, G. T. , Barnes, E. H. , Watson, D. I. , Ackland, S. P. , Martin, J. M. , Burge, M. , Finch, R. , Karapetis, C. S. , Shannon, J. , Nott, L. M. , Varma, S. , Marx, G. , Falk, G. L. , Gebski, V. , Oostendorp, M. , Wilson, K. , Thomas, J. , Lampe, G.
- Resource Type: journal article
- Date: 2020